Advertisement

Topics

TranS1 Company Profile

09:28 EDT 22nd June 2018 | BioPortfolio

TranS1 develops products to solve spinal pathologies while minimizing trauma to the tissues surrounding the spine. The company’s flagship product, AxiaLIF, is a minimally invasive option for surgeons to accomplish spinal fusion at the L5-S1 joint. AxiaLIF achieves a faster recovery time, cost savings, and lower incidence of complication compared to alternative procedures.


News Articles [7 Associated News Articles listed on BioPortfolio]

Three patents obtained by TranS1 for spinal health technologies

Two patents related to presacral interbody fusion have been secured by TranS1 for two new expandable cages designed for lordo -More- 

Global Trans1,2Dichloroethylene Market Analysis 20122017 and Forecast 20182023 [Report Updated: 17012018] Prices from USD $2980

SummaryThe global Trans1,2Dichloroethylene market will reach xxx Million USD in 2017 and CAGR xx% 20112017. The report begins from overview of Industry Chain structure, and describes industry environm...

Global Trans1,2Dichloroethylene Market Research Report 20112023 [Report Updated: 08012018] Prices from USD $1820

SummaryThe global Trans1,2Dichloroethylene market will reach xxx Million USD in 2017 with CAGR xx% 20182023. The objective of report is to define, segment, and project the market on the basis of produ...

Global and Europe Trans1, 2Dichloroethylene Market Status and Future Forecast 20132023 [Report Updated: 04012018] Prices from USD $3500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

20152023 World Trans1,2Dichloroethylene Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 01072017] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and en...

Global and China Trans1,2Dichloroethylene Market Research by Company, Type Application 20132025 [Report Updated: 06032018] Prices from USD $2000

SummaryMarket Segment as follows:By Type Polyurethane Polystyrene Polyvinyl Chloride Polyolefin OthersBy Application Solvent Cleaning Foam Blowing OthersBy Company PPG ...

Global Trans1,2Dichloroethylene Market Research Report 2018 [Report Updated: 08032018] Prices from USD $3500

SummaryMarket Segment as follows:By Region AsiaPacific North America Europe South America Middle East AfricaBy Type Polyurethane Polystyrene Polyvinyl Chloride Polyolefin ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

TranS1

TranS1 develops products to solve spinal pathologies while minimizing trauma to the tissues surrounding the spine. The company’s flagship product, AxiaLIF, is a minimally inv...

More Information about "TranS1" on BioPortfolio

We have published hundreds of TranS1 news stories on BioPortfolio along with dozens of TranS1 Clinical Trials and PubMed Articles about TranS1 for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TranS1 Companies in our database. You can also find out about relevant TranS1 Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record